Angulo JC, Virseda‐Chamorro M, Arance I, et al. - This study was attempted to test long‐term durability and effectiveness of the adjustable transobturator male system (ATOMS). Researchers updated retrospective multicenter Iberian ATOMS study (n = 215) to investigate long‐term continence status, complications, explants, and secondary treatments (mean follow‐up from surgery to March 2020 was 60.6 ± 18.4 months [range, 39‐91]). They applied Kaplan‐Meier curves to assess device durability and incontinence free of recurrence interval. The multivariate analysis was conducted to characterize the population at risk of device explant. ATOMS device was found to be an effective and safe in the long term. The data demonstrate that for device explant, determinants include complications, baseline severity of incontinence, and previous irradiation. Currently, after 5 years, the durability of the device is reassuring.